Imagion Biosystems has announced Results of its 2018 Annual General Meeting.
View Results of Annual General Meeting.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal